FDA posts CAP briefing documents

FDA posted briefing documents ahead of Wednesday's meeting of the Anti-Infective Drugs Advisory Committee to discuss unresolved issues for the design of clinical trials for community-acquired pneumonia (CAP) caused by bacterial pathogens. The committee will be asked to discuss and vote on five issues that were raised in comments on draft guidance published in March. ...